IGF1R and breast carcinoma: Advanced diagnostics and biomarker research are also central to the utilization of quantum dots in breast cancer, focusing on the early detection of mutations, such as those in the BRCA1 gene [18], and the quantitative analysis of cancer-related proteins like IGF1R [19].